Emily is a summer student in our Toronto office. She is currently completing her Juris Doctor from the University of Ottawa.
During her legal studies at the University of Ottawa, Emily volunteered as an Assistant Editor on the Ottawa Law Review. She received a Technoship Fellow award from the Law, Technology and Society (CLTS) at the University of Ottawa, where she performed research under the guidance of one of the Faculty of Law professors.
Emily joins Smart & Biggar with a Ph.D. in Physiology from the University of Toronto and a Bachelor of Science in Biomedical Science from York University. Before pursuing law, she gained experience working as a scientist genetically modifying pluripotent stem cells for cancer therapy. Following her Ph.D., she worked as a postdoctoral fellow where her research focus was to generate insulin producing cells for patients living with Type 1 Diabetes.
At the University of Toronto, Emily published five papers and one patent. She was awarded Oral Presentation winner at the University of Toronto’s annual Frontiers in Physiology Conference for her presentation about her thesis topic: Using stem cells for the treatment of Type 1 Diabetes. Emily also won the University of Toronto’s 3 Minute Thesis Competition, People’s Choice Award.
When completing her undergraduate studies, Emily received the York University Sport Excellence Award, awarded to students for their academic and athletic accomplishments. She competed on the York University Varsity Track & Field Team as well as the York University Varsity Cross Country Team for four years.
In her spare time, Emily enjoys running and competing in triathlons.
Qualifications
- News
- In the Media
Publications
- GP2-enriched pancreatic progenitors give rise to functional beta cells in vivo and eliminate the risk of teratoma formation. Stem Cell Reports. 2022.
- Sufu- and Spop-mediated downregulation of Hedgehog signaling promotes beta cell differentiation through organ-specific niche signals. Nature Communications. 10, 4647, 2019.
- Stem Cells, Self-Renewal, and Lineage Commitment in the Endocrine System. Frontiers in Endocrinology. 10 (2019).
- Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors. J. Vis. Exp. (121), e55265, doi:10.3791/55265, 2017.
- GP2 is a specific cell surface marker of human pancreatic progenitors. Nature Communications. 331, 2017.